Literature DB >> 12098788

Biochemical Characterization of PAI-2 and Its Mutants.

Yu Tian1, Jun-Qing Shen, Ping Li, Yun-Song Zhu.   

Abstract

To study and compare the biochemical characterization of PAI-2 and its mutants, PCR and site-directed mutagenesis methods were used to generate two PAI-2 mutants, PAI-2CD and PAI-2Q, respectively. The two mutant cDNAs were inserted into prokaryotic expression vector and expressed in a special strain of E.coli, JF1125. The expected PAI-2 mutant proteins were identified by SDS-PAGE, both covering about 14% of total bacteria proteins. The antigenicity and activity inhibiting uPA of the two mutant proteins were verified to be identical with that of wild PAI-2 by using Western blot and milk-agarose plate assay and reverse milk-agarose zymograph. The harvested recombinant bacterial cells growing in 5 L fermentor were homogenized and purified by the protocols including ammonium sulfate precipitation, Sephadex G-75 gel filtration, Q-Sepharose ion-exchange chromatography and hydrophobic interaction chromatography. The purity of the purified PAI-2CD and PAI-2Q was up to 98% and 90%, the protein yield was 18.4% and 22.1%, the specific activity was 28 640 u/mg and 14 836 u/mg, respectively. The results indicate that the biochemical characterization of PAI-2 mutants was very similar to those of the wide-type PAI-2 except that PAI-2Q can not be catalyzed by tTG.

Entities:  

Year:  2000        PMID: 12098788

Source DB:  PubMed          Journal:  Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai)        ISSN: 0582-9879


  1 in total

1.  A hybrid protein of the amino-terminal fragment of urokinase and mutant plasminogen activator inhibitor-2 efficiently inhibits tumor cell invasion and metastasis.

Authors:  Xia Wang; Min Hou; Li Tan; Xinghui Sun; Yuqing Zhang; Ping Li; Yunsong Zhu
Journal:  J Cancer Res Clin Oncol       Date:  2004-10-12       Impact factor: 4.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.